相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RA: AN INTEGRATED ANALYSIS
J. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis
Jeffrey R. Curtis et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Vaccinations for rheumatoid arthritis
Marcia A. Friedman et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies
Roy Fleischmann et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases Implications for Vaccination
Huifeng Yun et al.
ARTHRITIS & RHEUMATOLOGY (2016)
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATOLOGY (2016)
TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION UP TO 6 YEARS
J. Wollenhaupt et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Belimumab for Systemic Lupus Erythematosus: A Cochrane Systematic Review and MetaAnalysis
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis
Chul Won Jung et al.
LEUKEMIA & LYMPHOMA (2015)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
Juergen Wollenhaupt et al.
JOURNAL OF RHEUMATOLOGY (2014)
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Eun Bong Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Vaccinations for Rheumatoid Arthritis
Lisa M. Perry et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis A Randomized Trial
Joel Kremer et al.
ANNALS OF INTERNAL MEDICINE (2013)
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2013)
Varicella-Zoster Virus-Specific Antibody Responses in 50-59-Year-Old Recipients of Zoster Vaccine
Myron J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R. Burmester et al.
LANCET (2013)
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
Kenneth E. Schmader et al.
CLINICAL INFECTIOUS DISEASES (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Overview of safety of non-biologic and biologic DMARDs
Eric M. Ruderman
RHEUMATOLOGY (2012)
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S. van Assen et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Varicella Zoster Virus DNA at Inoculation Sites and in Saliva After Zostavax Immunization
Duane L. Pierson et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine
M. J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
MN Oxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
D Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2005)
分享论文
